Literature DB >> 10235092

Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.

G Paolisso1, M R Tagliamonte, M R Rizzo, A Gambardella, P Gualdiero, D Lama, G Varricchio, S Gentile, M Varricchio.   

Abstract

Previous studies have demonstrated that insulin resistance is a common feature of congestive heart failure (CHF), but the clinical significance of such insulin resistance is still debated. We tested the hypothesis that insulin-mediated glucose uptake (IMGU) is a prognostic factor in CHF in aged patients. For this purpose 174 aged patients with CHF participated in a cross-sectional and a longitudinal study of 24 months' duration. In this latter study survival analysis was calculated comparing subjects at the first and second tertile of IMGU with those at third tertile. All subjects underwent anthropometric (body mass index, waist/hip ratio), cardiovascular (arterial blood pressure, 24-hour Holter monitoring, peak VO2, left ventricular ejection fraction, echocardiography), and metabolic (determination of fasting plasma glucose, insulin, catecholamine, free fatty acids, tumor necrosis factor-alpha concentrations, and assessment of IMGU by euglycemic hyperinsulinemic glucose clamp) investigations. In the cross-sectional study, IMGU correlated with age (r = -0.33, p <0.001), body mass index (r = -0.46 p <0.001), ventricular premature complexes (r = -0.78, p <0.001), left ventricular ejection fraction (r = -0.15, p <0.05), fasting plasma norepinephrine (r = -0.75, p <0.001), tumor necrosis factor-alpha (r = -0.45, p <0.001), free fatty acids (r = -0.54, p <0.001), and peak VO2 (r = 0.67, p <0.001). In the longitudinal study patients at the first and second tertile of IMGU had a lower probability of survival than patients at the third tertile (p <0.03). Cox regression analysis showed IMGU to be a prognostic factor independent of fasting plasma norepinephrine, tumor necrosis factor-alpha, free fatty acid concentration, New York Heart Association class, peak VO2, and left ventricle ejection fraction (relative risk 1.1, 95% confidence intervals 1.0 to 2.1). In conclusion, our study demonstrates that insulin resistance is a common feature of CHF most likely due to elevated plasma norepinephrine and tumor necrosis factor-alpha concentrations, and that IMGU is an independent prognostic factor in CHF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235092     DOI: 10.1016/s0002-9149(99)00097-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Energetics and metabolism in the failing heart: important but poorly understood.

Authors:  Aslan T Turer; Craig R Malloy; Christopher B Newgard; Mihai V Podgoreanu
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

2.  Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway.

Authors:  Wei Gao; Hao Wang; Lin Zhang; Yang Cao; Ji-Zhang Bao; Zheng-Xia Liu; Lian-Sheng Wang; Qin Yang; Xiang Lu
Journal:  Endocrinology       Date:  2016-04-21       Impact factor: 4.736

Review 3.  Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.

Authors:  A P Bolger; S D Anker
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

4.  Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation.

Authors:  Raffay S Khan; Tomoko S Kato; Aalap Chokshi; Michael Chew; Shuiqing Yu; Christina Wu; Parvati Singh; Faisal H Cheema; Hiroo Takayama; Collette Harris; Gissette Reyes-Soffer; Ralph Knöll; Hendrik Milting; Yoshifumi Naka; Donna Mancini; P Christian Schulze
Journal:  Circ Heart Fail       Date:  2012-02-29       Impact factor: 8.790

5.  Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Chaoyang Li; Earl S Ford; Lisa C McGuire; Ali H Mokdad
Journal:  J Epidemiol Community Health       Date:  2007-01       Impact factor: 3.710

6.  Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.

Authors:  S Masi; R Lautamäki; L Guiducci; P Di Cecco; C Porciello; S Pardini; M A Morales; V Chubuchny; P A Salvadori; M Emdin; A M Sironi; J Knuuti; D Neglia; P Nuutila; E Ferrannini; P Iozzo
Journal:  Diabetologia       Date:  2012-07-01       Impact factor: 10.122

Review 7.  Glycemic control and treatment patterns in patients with heart failure.

Authors:  W H Wilson Tang
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

8.  A common trafficking route for GLUT4 in cardiomyocytes in response to insulin, contraction and energy-status signalling.

Authors:  Daniel J Fazakerley; Scott P Lawrence; Vladimir A Lizunov; Samuel W Cushman; Geoffrey D Holman
Journal:  J Cell Sci       Date:  2009-02-10       Impact factor: 5.285

Review 9.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

Review 10.  Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.

Authors:  Petra Mamic; Thanat Chaikijurajai; W H Wilson Tang
Journal:  J Mol Cell Cardiol       Date:  2020-12-09       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.